Methods and compositions for administration of iron for the treatment of restless leg syndrome

US6960571B2 · kind B2 · utility

Assignee

• Luitpold Pharmaceuticals, Inc. · US

Inventors

• Mary Jane Helenek · Brookville, US
• Ralf Lange · Krefeld, DE
• Fred B. Oldham · West Chester, US
• Marc L. Tokars · Douglassville, US

Key dates

• Filing date: Mar 14, 2003
• Grant date: Nov 1, 2005
• Expiry date: Mar 14, 2023

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A method of treating Restless Leg Syndrome, includes administering to a subject an iron complex having an iron release rate greater than IDI. The iron release rate is determined at a concentration of at least 2,000 μg/dl.